Please join the inaugural webcast “Tell Me Something I Don’t Know,” hosted by Children’s National Hospital (CNH) Innovation Ventures and the National Capital Consortium for Pediatric Device Innovation (NCC-PDI). In this episode, we learn about the process of selecting novel technologies for implementation at CNH. Jennifer Yin, MSN, RN, CVAHP, hospital’s Value Analysis Clinical Program Manager, will engage in a fireside chat with Francesca Joseph, MD, FAAP, Pediatrician at CNH and co-Investigator of NCC-PDI. Jennifer and Francesca will provide a general understanding of the Value Analysis process and highlight topics most relevant to medical device innovators.

A new 500,000 square-foot life science campus is being planned for Frederick County.

With two 100,000 square-foot research and development labs; two additional 145,000 square-foot production buildings; co-working space; conference rooms; and more, The Labs at Jefferson Tech Park will provide in demand, state-of-the-art space for life science companies looking to locate along the I-270 corridor.

The campus – which aims to be the “premier biodiscovery campus” in the county – is also expected to host numerous fitness and walking trails, outdoor green space, a cafe, and plenty of parking.

Individuals from diverse backgrounds can provide unique and valuable contributions in the research and development of life science innovations that prevent disease, prolong life, and promote health. However, certain groups, such as women and individuals from racial/ethnic minoritized groups, remain underrepresented in the U.S. biomedical sciences and in life science entrepreneurship.

Today, I am pleased to introduce the inaugural cohort of the NIH 21st Century Scholars Program—a new COSWD-sponsored initiative to promote awareness of the science of scientific workforce diversity. Six mentors and 13 cohort engagement participants from the NIH extramural scientific workforce were selected; together, they will build a vibrant, self-reinforcing culture of mentoring and support with a focus on diversity at the NIH.

ANNAPOLIS, MD—Governor Larry Hogan today announced a new Maryland Cancer Moonshot Initiative to expand and accelerate cancer detection, screening, prevention, treatment, and research in the state. The state is committing $216 million in investments as a down payment to jumpstart this far-reaching initiative to save lives, including the first ever comprehensive cancer center in Prince George’s County.

Image: https://governor.maryland.gov/

The NasaClip device provides simple and effective nosebleed rescue at home or anywhere, using hands-free, external nasal compression with intranasal sponges that medicine can be added to – helping to stop nosebleeds fast.

Image: https://www.tedcomd.com

A Brisbane-based company that has targeted the premium end of the COVID home diagnosis boom has officially opened its 20,000-square-metre facility in the US, but its founder is now nervous about a potential flu pandemic as "vaccine weariness" sets in.

Ellume founder and CEO Sean Parsons tells Business News Australia the opening of the facility in Frederick, Maryland moves "moves us into pretty rarefied air" of companies that have massive capability for manufacturing tests for COVID and other viruses, at around 500,000 per day.

One of the most impactful moments I’ve witnessed working in the life sciences sector happened on the campus of Edwards Lifesciences last year.

Just months after having surgery, a patient met face to face with the team behind her heart valve replacement. She got to thank the people who built and inspected the very device now helping her heart function properly. They hugged, they clapped. For many of the Edwards team, it was the first time they were able to meet a patient whose life they changed.

It’s not often we see these moments up close – the ones where it’s so clear why we do what we do in the life sciences. This is what we do—deliver innovative solutions for healthier lives.

Companies developing lab automation, ophthalmological treatments, and novel foods received Europe’s top biotech investments in February 2022.

European and Israeli biotech investments in February 2022 narrowly beat January’s performance. Life sciences companies in these regions bagged 52 private investments and initial public offerings (IPOs), worth €664M in total. Meanwhile, January’s tally was 41 deals totaling €660M. Neither month matched the biotech investment highs of December 2021.

Image: https://www.labiotech.eu

FREDERICK, Md. — The first company to make rapid take-home COVID-19 tests is now making them in Maryland.

A few months ago, it was nearly impossible to find an at-home COVID-19 test in stores across Maryland. Now, store shelves are stocked with boxes of test kits from different brands.

But it's not just about COVID-19 at Ellume's manufacturing plant In Frederick. The large manufacturing facility was built to support the federal government's response to the current pandemic and future ones.

Hailed as a medical breakthrough a year ago, Ellume's COVID-19 at-home test kits are rolling off a state-of-the-art assembly line in Frederick, which held its grand opening Thursday.

Image: https://www-wbaltv-com.cdn.ampproject.org

Life Sciences Business Strategist

BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland, DC and Virginia).  We are seeking a Life Sciences Business Strategist to join our team remotely.

The right candidate will be an energetic and continuous learner who is passionate about accelerating the adoption of new technologies to improve lives. The position is geared toward an early-career scientist (generally in their first 5-7 years after receiving their PhD) who wants to engage with the biohealth industry in new ways.  

WASHINGTON, DC and ROCKVILLE, Md., March 28, 2022 – The Federal Laboratory Consortium (FLC) has entered into a strategic partnership with Rockville Economic Development, Inc. (REDI), based in Rockville, MD as part of an ongoing campaign to help local businesses and entrepreneurs with innovative technologies succeed through collaborations with federal laboratories.

The Rockville Economic Development, Inc. (REDI) was formed in 1997 as a public-private partnership (formerly known as the Greater Rockville Partnership) by the City of Rockville, Maryland, to build the city’s economic base through entrepreneurship, expansion, retention, and recruitment programs. REDI and the FLC signed a Memorandum of Understanding on March 22, 2022.

The U.S. Senate confirmed Laurie Locascio, a former bioengineering professor at the University of Maryland, to helm the National Institute of Standards and Technology on Thursday.

Following Locascio’s nomination by President Joe Biden back in 2021, the Senate voted in her favor during an April 8 voice vote. Her nomination was first approved by the Senate Committee on Commerce, Science and Transportation before being sent to the floor for a final vote.

Image: J. STOUGHTON/NIST

For months, some American and European leaders have foretold that the coronavirus pandemic would soon become endemic. Covid-19 would resolve into a disease that we learn to live with. According to several governors, it nearly has.

But we are still in the acute phase of the pandemic, and what endemic Covid might look like remains a mystery. Endemic diseases can take many forms, and we do not know yet where this two-year-old disease will fall among them.

Image: https://www.nytimes.com

Modern Healthcare last week released its annual list of the "Top 25 Innovators," recognizing leaders who initiate and lead change in the health care industry.

Methodology For the list, Modern Healthcare accepted nominations from Nov. 22, 2021 to Jan. 31, 2022.

To be eligible, nominees had to be at the director level or higher within a provider organization—including a hospital, health system, clinic, or physician group—or an insurer. 

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen, a global healthcare solutions company, today announced the establishment of AB Health Ventures, a dedicated corporate venture capital fund that will invest in and partner with emerging healthcare startup companies working to transform healthcare for people and animals globally. AB Health Ventures will build on AmerisourceBergen’s ongoing commitment to delivering innovation for its customers.

The impacts of various ongoing developments, from the metaverse’s increasing prominence to the forthcoming gubernatorial shift, on Maryland’s tech economy were on the minds of attendees and panelists alike at last Thursday’s Digital Transformation Summit.

The Maryland Tech Council hosted its third iteration of the annual convention, in which the economic development group looks at the Maryland tech economy’s future, at the Maryland Jockey Club in Laurel.

Image: (L to R) Fearless' design director Jordan Watts; Exelon's principal product designer Chris-Anne Correa; Mindgrub's research and experience design director Shannon Hosmer; Christine Jackson, director of digital Strategy for the National Aquarium; and Solomon Scott, engineering lead, for The Washington Post, speak on a panel during the third annual Digital Transformation Summit. - https://technical.ly

GERMANTOWN, Md., April 6, 2022 /PRNewswire/ — BiOneCure Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the IND for BIO-106, an antibody-drug conjugate (ADC) designed to target TROP-2 to treat a broad range of advanced solid tumors.

 The clinical study cleared by the FDA, known as StarBridge-1, is a Phase I/II, multicenter, open-label study to evaluate the safety, pharmacokinetics and preliminary anti-tumor activity of BIO-106 as monotherapy and in combination with pembrolizumab in patients with advanced cancers.

John Newby is CEO of Virginia Bio, the nonprofit statewide trade association that serves and promotes the life sciences industry in the Commonwealth. VEDP Interim President and CEO Jason El Koubi spoke with Newby about recent life sciences success stories in the Commonwealth and Virginia Bio’s efforts to grow the industry, including the recently announced industry hub, Virginia Bio-Connect.

TUSCON, AZ / ACCESSWIRE / April 5, 2022 / AURP, the leading nonprofit representing research parks, innovation districts and regional technology clusters, today announced a realignment of its executive team to optimize AURP’s continued success and global development strategies.

Vickie Palmer, current Director of Operations, has been appointed AURP CEO. Palmer assumes this executive leadership role following her 15 years of experience significantly expanding AURP’s membership and sponsorship community, plus overseeing AURP’s roster of events and programs. During her time with AURP, Palmer has led the organization’s membership, event management and overall operations while working closely with the organization’s CEO, Board of Directors and membership community.

OLATHE, Kan., April 06, 2022--(BUSINESS WIRE)--Innara Health, the industry leader in feeding development for newborns and infants born prematurely is collaborating with Cardinal Health on the redesign of the NTrainer System. The next generation NTrainer will be smaller, more intuitive, and easier to integrate into NICU feeding protocols.

"We are thrilled to have a globally recognized organization like Cardinal Health support Innara and the NTrainer. Not only is this collaboration validating for our clients and our team, but it is also a clear indication of Cardinal Health’s commitment to improving clinical outcomes through innovation. We look forward to seeing their contributions toward providing preterm infants with their best opportunity to develop, grow, and thrive," stated Innara Health CEO Chris Mathia.

Adaptive Phage Therapeutics, Inc., a Gaithersburg, MD-based clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, raised $20m in further funding.

The AMR Action Fund has joined an existing $41m Series B round as a co-investor. The round was initiated in May 2021 and led by Deerfield Management Company, with participation from a second institutional investor and Mayo Clinic. Martin Heidecker, PhD, Chief Investment Officer of the AMR Action Fund, will join APT’s Board of Directors.

Image: https://www.finsmes.com

Three portfolio companies have graduated from the Germantown Innovation Center (GIC), Montgomery County's business incubator program. The County's incubator program started in 1999 to foster the growth and development of young technology companies. Akan Biosciences, Intelligent Fusion Technology and Seraxis are the three County-based companies graduating from the program this spring.

"Montgomery County continues to be the epicenter of bio health and information technology in the region," said County Executive Marc Elrich. "Congratulations to Akan Bio, Intelligent Fusion Technology, and Seraxis on their graduation from our incubator. We are excited for their continued growth in the County. Montgomery County is committed to having an economic development environment that fosters growth and entrepreneurship, and these graduates are just the most recent example of the great work happening in our incubators and throughout the County."

These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.

To sign-up for any of the EIR dates in 2022, please follow this link.

GAITHERSBURG, Md., April 01, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc.,  (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has enrolled the first subject in the 48-week Phase 2 MOMENTUM trial evaluating the safety and efficacy of pemvidutide1 in subjects with obesity or overweight. Pemvidutide is a novel, investigational GLP-1/glucagon dual receptor agonist under development for the treatment of obesity and non-alcoholic steatohepatitis (NASH). The Company also today announced the completion of enrollment in its 12-week Phase 1b clinical trial of pemvidutide in subjects with non-alcoholic fatty liver disease (NAFLD).

GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that the AMR Action Fund has joined an existing $41 million Series B round as a co-investor. The round was initiated in May 2021 and led by Deerfield Management Company, with participation from a second institutional investor and Mayo Clinic. Proceeds of the AMR Action Fund’s investment are primarily intended to support APT’s clinical trials to address substantial unmet patient needs in Prosthetic Joint Infection (PJI) and Diabetic Foot Osteomyelitis (DFO).

Image: ttps://www.businesswire.com

The Office of the Provost has appointed Brian Coblitz to be the new executive director of George Washington University’s Technology Commercialization Office (TCO).

TCO promotes and facilitates the transfer of technology developed at GW for the benefit of the university community and the public while leveraging GW resources by partnering with industry experts and entrepreneurs. Coblitz, who was previously interim director of the office and managed licensing for GW's life science technologies for nine years, has been with TCO since 2012.

Image: Brian Coblitz, executive director of GW Technology Commercialization Office. (Maansi Srivastava/GW Today) - https://gwtoday.gwu.edu

It’s decided. President Joe Biden’s new biomedical research agency for high-risk, cutting-edge research won’t have the full autonomy many backers had sought. Instead, it will sit within the National Institutes of Health (NIH). But to give the agency a measure of independence, its director will report to the NIH director’s boss, the secretary of health and human services (HHS).

Image: Xavier Becerra, secretary of health and human services, testified today before a House of Representatives spending panel that oversees the National Institutes of Health.AP PHOTO/J. SCOTT APPLEWHITE

FREDERICK, Md., March 31, 2022 /PRNewswire/ -- Digital diagnostics company Ellume, a producer of at-home COVID-19 test kits, today officially opened its new, 215,000 square foot production facility in Frederick, Maryland. Joined by Maryland Governor Larry Hogan, Ellume Founder and Chief Executive Officer Dr. Sean Parsons inaugurated the new facility, which has the capacity to produce approximately 15 million COVID-19 Home Tests per month and will create hundreds of new jobs.

"From the very onset of the COVID-19 pandemic, Ellume has been committed to supporting the U.S. government's response. With this new facility, we now have the capacity to substantially scale production to meet any future surge in demand for home tests, while also accelerating innovation in developing solutions for the public health needs of today and tomorrow," said Dr. Sean Parsons, Ellume Founder and CEO. "We are grateful for the support of the US Department of Defense, US Department of Health and Human Services, our partnerships with the State of Maryland, the Governor's office and Frederick County, as well as the highly skilled workforce in Maryland's Biotech Corridor who have helped make this facility a reality."

PASADENA, Calif., March 31, 2022 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life science, agtech and technology campuses in AAA innovation cluster locations, today announced that it was recognized by AgFunder in its "2022 AgriFoodTech Investment Report" as one of the top five most active U.S. investors in agrifoodtech by number of companies in which it invested (2021) for the second consecutive year. This significant recognition demonstrates Alexandria's leadership in venture activity that supports the next generation of companies in agrifoodtech. These impactful companies are accelerating and scaling technological innovation and broader transformations in the agrifoodtech sector, which are critical for the long-term health, accessibility, sustainability and resilience of the global food supply. Since 2000, Alexandria has diligently invested in and provided state-of-the-art infrastructure for innovative agrifoodtech companies advancing novel approaches with vast potential to address challenges related to sustainability, agriculture, food and nutrition.

We are excited to announce that Virginia Bio Connect has launched the first centralized asset resource portal VABIOCONNECT.ORG! This portal is your destination for Virginia’s life sciences resources, jobs, and events. It’s a place to connect and follow people and organizations from the ecosystem. Visit https://vabioconnect.org/ and create your profile today!

MEDA Angels is pleased to announce that it has entered into a Partnership with Tech Coast Angels (TCA) of Southern California. TCA, founded in 1997, is a leading source of angel investor funding of seed-stage and early-stage companies. It has invested more than $255 million in more than 500 companies and has helped attract more than $1.7 billion in additional capital/follow-on rounds.  

MEDA Angels, an angel investor group established in 2019, was founded by seasoned physician- and scientist-investors. Its healthcare-centric membership includes 50+ physicians, scientists, and other healthcare experts, as well as legal, financial, and regulatory professionals. Since its inception, MEDA Angels has invested in 12 companies, totaling nearly $2 million. With one exit providing a 2x ROI & 80% IRR, the unrealized gains from its existing portfolio investments stand at 1.9x ROI and 86% IRR.

WHEN: Today, Wednesday, March 30, 2022 

WHERE: CNBC’s “Healthy Returns Summit: Reality, Recovery and Opportunity”

Following is the unofficial transcript of a CNBC interview with Johnson & Johnson CEO Joaquin Duato and CNBC’s Senior Health & Science Reporter Meg Tirrell live during CNBC’s “Healthy Returns Summit: Reality, Recovery and Opportunity” today, Wednesday, March 30th.

Image: https://www.jnj.com/leadership/joaquin-duato

Researchers say the sensor combines accuracy levels approaching that of PCR testing with the speed of rapid antigen tests, and could be used for mass testing at airports, schools, and hospitals  

Catherine Graham March 29, 2022  

A COVID-19 sensor developed at Johns Hopkins University could revolutionize virus testing by adding accuracy and speed to a process that frustrated many during the pandemic.  

In a new study published today in Nano Letters, the researchers describe the sensor, which requires no sample preparation and minimal operator expertise, offering a strong advantage over existing testing methods, especially for population-wide testing.  

President Joe Biden didn’t forget research today, when he submitted to Congress a 2023 budget request that calls for a 9.5% increase in domestic discretionary spending. Biden is asking for a 19% increase at the National Science Foundation (NSF), a 9.6% boost for the National Institutes of Health (NIH), 4.5% more for the Department of Energy’s (DOE’s) Office of Science, and a 5% hike for NASA’s science missions. Once again, fighting climate change and boosting sustainable energy technologies also rank high among Biden’s research priorities.

Image: https://www.whitehouse.gov/administration/president-biden/